Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

被引：0
|
作者：
T Aparicio
E Mitry
J Ezenfis
S Dominguez
机构：
[1] Hôpital Bichat-Claude Bernard,
[2] AP-HP,undefined
[3] Service d'Hepato-Gastroenterologie,undefined
[4] 46 rue Henri Huchard,undefined
[5] Service d' Hépeto-gastroentérologie,undefined
[6] Hôpital Ambraise Peré,undefined
[7] AP-HP,undefined
[8] Service d' Hépeto-gastroentérologie,undefined
[9] Hôpital ole Longjumean,undefined
[10] Départment Uro-Digesvif,undefined
[11] Centre Oscan Lambret,undefined
来源：
British Journal of Cancer | 2004年 / 90卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2051 / 2052
页数：1
相关论文
共 50 条
  • [1] Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Mitry, E
    Ezenfis, J
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 2051 - 2052
  • [2] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Alliot, C
    Barrios, M
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 2050 - 2051
  • [3] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    T Aparicio
    J Desramé
    T Lecomte
    E Mitry
    J Belloc
    I Etienney
    S Montembault
    L Vayre
    C Locher
    J Ezenfis
    P Artru
    M Mabro
    S Dominguez
    British Journal of Cancer, 2003, 89 : 1439 - 1444
  • [4] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Desramé, J
    Lecomte, T
    Mitry, E
    Belloc, J
    Etienney, I
    Montembault, S
    Vayre, L
    Locher, C
    Ezenfis, J
    Artru, P
    Mabro, M
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1439 - 1444
  • [5] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    C Alliot
    M Barrios
    British Journal of Cancer, 2004, 90 : 2050 - 2051
  • [6] aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
    Fujita, Yoshihiko
    Taguri, Masataka
    Yamazaki, Kentaro
    Tsurutani, Junji
    Sakai, Kazuko
    Tsushima, Takahiro
    Nagase, Michitaka
    Tamagawa, Hiroshi
    Ueda, Shinya
    Tamura, Takao
    Tsuji, Yasushi
    Murata, Kohei
    Taira, Koichi
    Denda, Tadamichi
    Moriwaki, Toshikazu
    Funai, Sadao
    Nakajima, Takako Eguchi
    Muro, Kei
    Tsuji, Akihito
    Yoshida, Motoki
    Suyama, Koichi
    Kurimoto, Takuya
    Sugimoto, Naotoshi
    Baba, Eishi
    Seki, Nobuhiko
    Sato, Mikio
    Shimura, Takaya
    Boku, Narikazu
    Hyodo, Ichinosuke
    Yamanaka, Takeharu
    Nishio, Kazuto
    ONCOLOGIST, 2019, 24 (03): : 327 - 337
  • [7] KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin- or irinotecan-based treatment
    Soeda, Hiroshi
    Shimodaira, Hideki
    Waianabe, Mika
    Suzuki, Takao
    Gamo, Makio
    Takahashi, Masanobu
    Komine, Keigo
    Kato, Shunsuke
    Ishioka, Chikashi
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (03) : 356 - 362
  • [8] Efficacy of Postoperative Oxaliplatin- or Irinotecan-based Chemotherapy After Curative Resection of Synchronous Liver Metastases from Colorectal Cancer
    Hsu, Hung-Chih
    Chou, Wen-Chi
    Shen, Wen-Chi
    Wu, Chiao-En
    Chen, Jen-Shi
    Liau, Chi-Ting
    Lin, Yung-Chang
    Yang, Tsai-Sheng
    ANTICANCER RESEARCH, 2013, 33 (08) : 3317 - 3325
  • [9] Outcomes of Irinotecan-Based Chemotherapy Regimens in Elderly Medicare Patients With Metastatic Colorectal Cancer
    Obeidat, Nour A.
    Pradel, Francoise G.
    Zuckerman, Ilene H.
    DeLisle, Sylvain
    Mullins, C. Daniel
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2009, 7 (06): : 343 - 354
  • [10] Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic review
    Petrelli, Fausto
    Inno, Alessandro
    Ghidini, Antonio
    Rimassa, Lorenza
    Tomasello, Gianluca
    Labianca, Roberto
    Barni, Sandro
    EUROPEAN JOURNAL OF CANCER, 2017, 81 : 174 - 182
12345